GlaxoSmithKline (CAI:BIOC) Interest Expense: E£-65 Mil (TTM As of Sep. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is GlaxoSmithKline Interest Expense?

GlaxoSmithKline CAI:BIOC +9.94% Interest Expense is E£-65 Mil as of Sep. 2016.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. GlaxoSmithKline's interest expense for the three months ended in Sep. 2016 was E£ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2016 was E£-65 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. GlaxoSmithKline's Operating Income for the three months ended in Sep. 2016 was E£ 107 Mil. GlaxoSmithKline's Interest Expense for the three months ended in Sep. 2016 was E£ -1 Mil. GlaxoSmithKline's Interest Coverage for the quarter that ended in Sep. 2016 was 132.05. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GlaxoSmithKline  (CAI:BIOC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GlaxoSmithKline's Interest Expense for the three months ended in Sep. 2016 was E£-1 Mil. Its Operating Income for the three months ended in Sep. 2016 was E£107 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2016 was E£0 Mil.

GlaxoSmithKline's Interest Coverage for the quarter that ended in Sep. 2016 is calculated as

Interest Coverage=-1* Operating Income (Q: Sep. 2016 )/Interest Expense (Q: Sep. 2016 )
=-1*107.09/-0.811
=132.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

GlaxoSmithKline Interest Expense Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Interest Expense Chart

GlaxoSmithKline Annual Data
Trend Dec12 Dec13 Dec14 Dec15
Interest Expense
0.00 0.00 -1.75 -18.79

GlaxoSmithKline Quarterly Data
Dec12 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.86 -6.41 -58.24 0.00 -0.81

GlaxoSmithKline Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of E£-65 Mil mean?
GlaxoSmithKline (CAI:BIOC) has a Interest Expense of E£-65 Mil as of Sep. 2016. Interest Expense is the amount a company pays on its long-term debt. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's Interest Expense too high?
GlaxoSmithKline's current Interest Expense is E£-65 Mil.
How does GlaxoSmithKline's Interest Expense compare to PRPH?
GlaxoSmithKline's Interest Expense of E£-65 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on GlaxoSmithKline and its competitors. GlaxoSmithKline's current Interest Expense is E£-65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current Interest Expense of E£-65 Mil. The current Interest Expense is E£-65 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current Interest Expense is E£-65 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.